Compliance

PeptiDream Group's Corporate Code of Conduct

Recognizing that fulfilling our corporate social responsibilities enhances our corporate value, we at PeptiDream are committed to responsible business practice and faithfully comply with the provisions set forth herein.

Learn more

Sales activities based on fair competition

The Federation of Pharmaceutical Manufacturers' Associations of Japan (FPMAJ) formulated the "Code of Ethical Practice for Pharmaceutical Companies" in 1983 as a code of ethics for pharmaceutical companies dedicated to protecting people's lives. In this spirit, the Japan Pharmaceutical Manufacturers Association (JPMA) established the "Promotion Code for Prescription Drugs" in 1993. Then, this "Promotion Code for Prescription Drugs" was further revised to the "JPMA Code of Practice" in January 2013, formulating the standards of conduct governing interactions of company officers and employees with researchers, healthcare providers, patient groups, and others.

Respecting this spirit, we presented the "PDR Code of Practice (including "PDR Promotion Code for Prescription Drugs")" based on the above codes. Our employees comply with these rules and are engaged in sales activities based on fair competition.

Fair R&D programs

PDRadiopharma Inc. complies with the "Act on Welfare and Management of Animals" and related laws and regulations. To respect the principles of 3Rs*¹ in animal testing, "Regulations on Animal Experimentation" have been formulated and the Institutional Animal Care and Use Committee has been established to properly conduct animal testing and perform education, training, and self-inspections. In addition, our Chiba Factory has been evaluated and certified by the Japan Pharmaceutical Information Center for proper conduct of animal testing.

*1) 3Rs: Replacement: use of alternative methods, Reduction: use of fewer animals, Refinement: alleviation of pain